Atıf İçin Kopyala
Jackson A. M., Jhund P. S., Anand I. S., Düngen H., Lam C. S. P., Lefkowitz M. P., ...Daha Fazla
European heart journal, cilt.42, sa.36, ss.3741-3752, 2021 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
42
Sayı:
36
-
Basım Tarihi:
2021
-
Doi Numarası:
10.1093/eurheartj/ehab499
-
Dergi Adı:
European heart journal
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
-
Sayfa Sayıları:
ss.3741-3752
-
Anahtar Kelimeler:
Heart failure, Preserved ejection fraction, Sacubitril-valsartan, Blood pressure, DOUBLE-BLIND, BLOOD-PRESSURE, RECEPTOR, NEPRILYSIN, SPIRONOLACTONE, INHIBITOR, LCZ696, DOXAZOSIN, PLACEBO
-
Dokuz Eylül Üniversitesi Adresli:
Evet
Özet
Aims Patients with heart failure and preserved ejection fraction (HFpEF) frequently have difficult-to-control hypertension. We examined the effect of neprilysin inhibition on 'apparent resistant hypertension' in patients with HFpEF in the PARAGON-HF trial, which compared the effect of sacubitril-valsartan with valsartan.